跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
INCRELEX - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
INCRELEX
Authorized
STANDARD
INCRELEX
ipsen biopharmaceuticals canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
69ac609693f4b206
Company
ipsen biopharmaceuticals canada inc
Type
Standard
Approval Details
Approval Id
69ac609693f4b206
Drug Approval Canada Name
INCRELEX
Product Name
INCRELEX
Status
Marketed
Status Date
2021-03-01
Original Market Date
2021-03-01
Din
02509733
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Prescription , Schedule D
Ahfs
68:30.04
Atc Original
H01AC03 MECASERMIN
Atc Name
h 01 ac 03
Aig Number
0162642001
Company Name
ipsen biopharmaceuticals canada inc
Company Address
SUITE 500, 5050 Satellite Drive, Mississauga, Ontario, Canada, L4W 0G1
Active Ingredients
MECASERMIN
40 MG / 4 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
69ac609693f4b206
Type
Standard
Back to Health Canada Approvals